Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23

Kean T. Oh, Reid Longmuir, Dawn M. Oh, Edwin M. Stone, Kelly Kopp, Jeremiah Brown, Gerald A. Fishman, Peter Sonkin, Karen M. Gehrs, Richard Weleber

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

PURPOSE: To examine the difference in expression of retinitis pigmentosa from mutations at codon 23 and codon 347 or rhodopsin; to report a novel mutation in rhodopsin. METHODS: Goldmann perimetry (solid angle of I4e isopter) and electroretinographic amplitudes (square root transform of a response ratio) were analyzed for 24 patients with mutations at codon 347 (15 with Pro347Ala, 2 with Pro347Gln, 6 with Pro347Leu, and 1 with a novel Pro347Cys change) and 41 patients with mutations at codon 23 (6 with Pro23Ala; 35 with Pro23His). RESULTS: When all patients with mutations at codons 347 and 23 were compared, loss of visual fields was significantly worse in patients with codon 347 changes (P = .0003). Only rod responses of the electroretinograms were significantly different between the two groups (P = .048). Specific comparison of Pro347Ala with Pro23Ala using regression analysis demonstrated significant differences in severity between codon 23 and codon 347 patients for b-wave amplitudes of rod (P = .0069), cone (P = .039) and maximum combined response (P = .049). The solid angle of the I4e isopter was also significantly different (P = .025) between the groups after controlling for age. Modeling age by group for Pro347Ala comparison produced an R2 of .44. CONCLUSION: We reconfirmed that rhodopsin-related retinitis pigmentosa from mutations involving codon 347 produces a more severe phenotype than that involving codon 23. Accurate modeling of disease was shown to be possible by incorporating the effects of a patient's age and specific genotype. Therefore, both of these variables must be considered in prognostic counseling and subject recruitment for future therapeutic trials.

Original languageEnglish (US)
Pages (from-to)306-313
Number of pages8
JournalAmerican Journal of Ophthalmology
Volume136
Issue number2
DOIs
StatePublished - Aug 1 2003

Fingerprint

Retinitis Pigmentosa
Rhodopsin
Codon
Mutation
Visual Field Tests
Visual Fields
Counseling
Age Groups
Genotype
Regression Analysis
Phenotype

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23. / Oh, Kean T.; Longmuir, Reid; Oh, Dawn M.; Stone, Edwin M.; Kopp, Kelly; Brown, Jeremiah; Fishman, Gerald A.; Sonkin, Peter; Gehrs, Karen M.; Weleber, Richard.

In: American Journal of Ophthalmology, Vol. 136, No. 2, 01.08.2003, p. 306-313.

Research output: Contribution to journalArticle

Oh, Kean T. ; Longmuir, Reid ; Oh, Dawn M. ; Stone, Edwin M. ; Kopp, Kelly ; Brown, Jeremiah ; Fishman, Gerald A. ; Sonkin, Peter ; Gehrs, Karen M. ; Weleber, Richard. / Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23. In: American Journal of Ophthalmology. 2003 ; Vol. 136, No. 2. pp. 306-313.
@article{1cc79a09f1b54554b91399a0426adf7b,
title = "Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23",
abstract = "PURPOSE: To examine the difference in expression of retinitis pigmentosa from mutations at codon 23 and codon 347 or rhodopsin; to report a novel mutation in rhodopsin. METHODS: Goldmann perimetry (solid angle of I4e isopter) and electroretinographic amplitudes (square root transform of a response ratio) were analyzed for 24 patients with mutations at codon 347 (15 with Pro347Ala, 2 with Pro347Gln, 6 with Pro347Leu, and 1 with a novel Pro347Cys change) and 41 patients with mutations at codon 23 (6 with Pro23Ala; 35 with Pro23His). RESULTS: When all patients with mutations at codons 347 and 23 were compared, loss of visual fields was significantly worse in patients with codon 347 changes (P = .0003). Only rod responses of the electroretinograms were significantly different between the two groups (P = .048). Specific comparison of Pro347Ala with Pro23Ala using regression analysis demonstrated significant differences in severity between codon 23 and codon 347 patients for b-wave amplitudes of rod (P = .0069), cone (P = .039) and maximum combined response (P = .049). The solid angle of the I4e isopter was also significantly different (P = .025) between the groups after controlling for age. Modeling age by group for Pro347Ala comparison produced an R2 of .44. CONCLUSION: We reconfirmed that rhodopsin-related retinitis pigmentosa from mutations involving codon 347 produces a more severe phenotype than that involving codon 23. Accurate modeling of disease was shown to be possible by incorporating the effects of a patient's age and specific genotype. Therefore, both of these variables must be considered in prognostic counseling and subject recruitment for future therapeutic trials.",
author = "Oh, {Kean T.} and Reid Longmuir and Oh, {Dawn M.} and Stone, {Edwin M.} and Kelly Kopp and Jeremiah Brown and Fishman, {Gerald A.} and Peter Sonkin and Gehrs, {Karen M.} and Richard Weleber",
year = "2003",
month = "8",
day = "1",
doi = "10.1016/S0002-9394(03)00206-X",
language = "English (US)",
volume = "136",
pages = "306--313",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23

AU - Oh, Kean T.

AU - Longmuir, Reid

AU - Oh, Dawn M.

AU - Stone, Edwin M.

AU - Kopp, Kelly

AU - Brown, Jeremiah

AU - Fishman, Gerald A.

AU - Sonkin, Peter

AU - Gehrs, Karen M.

AU - Weleber, Richard

PY - 2003/8/1

Y1 - 2003/8/1

N2 - PURPOSE: To examine the difference in expression of retinitis pigmentosa from mutations at codon 23 and codon 347 or rhodopsin; to report a novel mutation in rhodopsin. METHODS: Goldmann perimetry (solid angle of I4e isopter) and electroretinographic amplitudes (square root transform of a response ratio) were analyzed for 24 patients with mutations at codon 347 (15 with Pro347Ala, 2 with Pro347Gln, 6 with Pro347Leu, and 1 with a novel Pro347Cys change) and 41 patients with mutations at codon 23 (6 with Pro23Ala; 35 with Pro23His). RESULTS: When all patients with mutations at codons 347 and 23 were compared, loss of visual fields was significantly worse in patients with codon 347 changes (P = .0003). Only rod responses of the electroretinograms were significantly different between the two groups (P = .048). Specific comparison of Pro347Ala with Pro23Ala using regression analysis demonstrated significant differences in severity between codon 23 and codon 347 patients for b-wave amplitudes of rod (P = .0069), cone (P = .039) and maximum combined response (P = .049). The solid angle of the I4e isopter was also significantly different (P = .025) between the groups after controlling for age. Modeling age by group for Pro347Ala comparison produced an R2 of .44. CONCLUSION: We reconfirmed that rhodopsin-related retinitis pigmentosa from mutations involving codon 347 produces a more severe phenotype than that involving codon 23. Accurate modeling of disease was shown to be possible by incorporating the effects of a patient's age and specific genotype. Therefore, both of these variables must be considered in prognostic counseling and subject recruitment for future therapeutic trials.

AB - PURPOSE: To examine the difference in expression of retinitis pigmentosa from mutations at codon 23 and codon 347 or rhodopsin; to report a novel mutation in rhodopsin. METHODS: Goldmann perimetry (solid angle of I4e isopter) and electroretinographic amplitudes (square root transform of a response ratio) were analyzed for 24 patients with mutations at codon 347 (15 with Pro347Ala, 2 with Pro347Gln, 6 with Pro347Leu, and 1 with a novel Pro347Cys change) and 41 patients with mutations at codon 23 (6 with Pro23Ala; 35 with Pro23His). RESULTS: When all patients with mutations at codons 347 and 23 were compared, loss of visual fields was significantly worse in patients with codon 347 changes (P = .0003). Only rod responses of the electroretinograms were significantly different between the two groups (P = .048). Specific comparison of Pro347Ala with Pro23Ala using regression analysis demonstrated significant differences in severity between codon 23 and codon 347 patients for b-wave amplitudes of rod (P = .0069), cone (P = .039) and maximum combined response (P = .049). The solid angle of the I4e isopter was also significantly different (P = .025) between the groups after controlling for age. Modeling age by group for Pro347Ala comparison produced an R2 of .44. CONCLUSION: We reconfirmed that rhodopsin-related retinitis pigmentosa from mutations involving codon 347 produces a more severe phenotype than that involving codon 23. Accurate modeling of disease was shown to be possible by incorporating the effects of a patient's age and specific genotype. Therefore, both of these variables must be considered in prognostic counseling and subject recruitment for future therapeutic trials.

UR - http://www.scopus.com/inward/record.url?scp=0041848367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041848367&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(03)00206-X

DO - 10.1016/S0002-9394(03)00206-X

M3 - Article

VL - 136

SP - 306

EP - 313

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 2

ER -